Evaluation of Music on the Level of Anxiety Felt During External Radiotherapy Sessions
MUSIC-RT
Prospective and Monocentric Pilot Study of the Evaluation of the Music Delivered by the Music-Care Device on the Level of Anxiety Felt During External Radiotherapy Sessions
2 other identifiers
observational
83
1 country
1
Brief Summary
This is a prospective study with a historical comparator. Each of the prospective study endpoints will be compared to data collected retrospectively in patients treated with radiation therapy prior to the implementation of the MUSIC-CARE device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2022
CompletedFirst Submitted
Initial submission to the registry
January 25, 2022
CompletedFirst Posted
Study publicly available on registry
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2023
CompletedApril 4, 2024
September 1, 2022
8 months
January 25, 2022
April 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The main objective of the study is to evaluate the impact of the MUSIC-CARE device on the level of anxiety perceived by patients during radiotherapy.
Perceived anxiety will be measured by the anxiety score (total A), assessed with the Hospital Anxiety and Depression Scale (HADS). To screen for anxiety symptomatology, the following interpretation is: Total A score at 7 or less: no symptomatology, Total A score of 8 to 10: questionable symptomatology, and Total A score equal to 11 and above: definite symptomatology. Anxiety will be assessed at the medical consultation, after 5 sessions and at the end of the treatment. The patients' score after 5 sessions will be used as the primary endpoint to evaluate the impact of the to evaluate the impact of the device.
The analysis will take place after the last visit (usual 6-month visit) of the last included patient, i.e. 6 months after the end of treatment of the last patient, and within a maximum of one year after this visit.
Study Arms (1)
Prospective phase
This prospective phase involves all patients with an initial HADS score \> 7 and initiating treatment in the radiotherapy department. The treatment sessions will be performed with music, using the MUSIC-CARE device. In the event of technical problems, unavailability of equipment, or the patient's wishes, some radiotherapy sessions may be conducted without music. Nevertheless, a minimum of one weekly session with music is required for the analysis of the study.
Interventions
This device allows the listening of music using different sequences of instrumental music created specifically, and using principles based on hypno-analgesia, that is to say the association of hypnotic techniques and approaches to help or analgesic, medicated or not. It consists of a tablet application containing instrumental music pieces, specially created and recorded for Music-Care. Each piece is at least 20 minutes long. The music can be played through headphones or speakers.
Eligibility Criteria
All patients, all cancers combined, with an initial HADS score \> 7 and initiating treatment in the radiotherapy department are concerned by this study.
You may qualify if:
- Patients over 18 years of age
- Patients undergoing radiotherapy for curative treatment
- Patients with at least 15 sessions of radiotherapy
- Patients with an anxiety score \> 7 on the total A of the HADS scale at the time of medical consultation
You may not qualify if:
- Minor patients
- Pregnant or breastfeeding patients
- Patients with major hearing loss
- Patients with psychotic disorders
- Patients who do not understand or read the French language
- Patients under guardianship or deprived of liberty
- Patients requiring radiotherapy with respiratory servo-control (the MUSIC-CARE cannot be used due to technical constraints)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre de Lutte contre le Cancer Eugène Marquis
Rennes, Brittany Region, 35042, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Coralie Hulot
Centre de Lutte contre le Cancer Eugène Marquis
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2022
First Posted
March 21, 2022
Study Start
January 18, 2022
Primary Completion
August 31, 2022
Study Completion
March 26, 2023
Last Updated
April 4, 2024
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share